| 摘要 |
The present invention provides a pharmaceutical composition for treating lung carcinoma and a diagnostic agent for lung carcinoma. More specifically, the present invention provides a pharmaceutical composition for treating lung carcinoma and a diagnostic agent for lung carcinoma, which comprise an antibody capable of binding to the beta-chain of an interleukin-20 receptor, and a method for detecting lung carcinoma, which comprises detecting the expression of the beta-chain of an interleukin-20 receptor in a sample obtained from a mammal suspected to have lung carcinoma.
|
